Juno Therapeutics, Inc.

We have merged with Bristol Myers Squibb creating a leading biopharma company, ideally positioned to discover, develop and deliver innovative medicines for patients fighting serious diseases. Visit www.bms.com to learn more about our work to produce the next generation of medicines to treat cancer and other serious diseases. For more information on the acquisition, see our press release at: https://bit.ly/3UbQcnl

网站

https://www.bms.com

Juno Therapeutics, Inc.的外部链接

所属行业

生物技术研究

规模

501-1,000 人

总部

Seattle，WA

类型

上市公司

领域

Biotechnology、Immunotherapy和cell therapy